Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
EMC Corporation this week announced the new Symmetrix DMX-3 system a next-generation high-end storage platform of the company's Symmetrix DMX-2 Series of systems.
The American Society for Therapeutic Radiology and Oncology (ASTRO) has announced the recipients of its 2005 Junior Faculty Career Research Training Award, Residents/Fellows in Radiation Oncology Research Seed Grants.
Over the next few weeks the Certification Commission for Healthcare Information Technology (CCHIT) is seeking comments from healthcare stakeholders regarding Phase II of its project to create a mechanism for the certification of HIT products.
Enterprise access security system provider Encentuate Inc. has announced a marketing and technology integration partnership with Carefx Corporation, a developer of healthcare clinical context management and web integration software.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
